IRF6

IRF6

Target · Transcription factor

IRF6 Interferon regulatory factor 6 · Van der Woude syndrome protein

IRF6 (interferon regulatory factor 6; also OFC6, VWS1, VWS and LPS) is a probable DNA-binding transcriptional activator of the IRF family. It is a key determinant of the keratinocyte proliferation-differentiation switch during epidermal development. Browse Assay Genie's current range of IRF6 research reagents below, or read on for the biology behind the target.

Nucleus and cytoplasmTranscriptional activatorLinked to Van der Woude syndrome
467 aa
Protein length
~53 kDa
Molecular weight
1q32.2
Gene locus
IRF family
Protein family
Target information

What is IRF6 (interferon regulatory factor 6)?

IRF6 is a probable DNA-binding transcriptional activator. It acts as a key determinant of the keratinocyte proliferation-differentiation switch, which is needed for appropriate epidermal development. It also plays a role in regulating mammary epithelial cell proliferation, and it may regulate transcription of WDR65. UniProt records the IRF6 protein in both the nucleus and the cytoplasm.

The IRF6 gene encodes a member of the interferon regulatory transcription factor family. Members of this family share a highly conserved N-terminal helix-turn-helix DNA-binding domain and a less conserved C-terminal protein-binding domain. HGNC places the gene in the interferon regulatory factors group. Alternate splicing of the IRF6 gene results in multiple transcript variants. The mouse ortholog is Irf6.

IRF6 is best known for its disease associations. Mutations in the gene can cause van der Woude syndrome and popliteal pterygium syndrome, and they are also associated with non-syndromic orofacial cleft type 6. This history is reflected in the aliases: VWS and VWS1 derive from Van der Woude syndrome, the previous HGNC name, and OFC6 refers to orofacial cleft 6. These links make IRF6 a frequent subject in craniofacial and epithelial biology.

Epidermal development

IRF6 is a key determinant of the keratinocyte proliferation-differentiation switch involved in appropriate epidermal development.

Craniofacial disorder research

Mutations in IRF6 cause van der Woude syndrome and popliteal pterygium syndrome, and are associated with non-syndromic orofacial cleft type 6.

Mammary epithelial biology

IRF6 plays a role in regulating mammary epithelial cell proliferation, making it relevant to studies of epithelial growth control.

Transcriptional regulation

As a probable DNA-binding transcriptional activator that may regulate WDR65, IRF6 is a candidate for gene-regulation studies.

Background

IRF6 frequently asked questions

What does IRF6 do?

IRF6 is a probable DNA-binding transcriptional activator. It is a key determinant of the keratinocyte proliferation-differentiation switch involved in epidermal development, and it helps regulate mammary epithelial cell proliferation. It may also regulate WDR65 transcription.

What other names does IRF6 have, and does it have isoforms?

IRF6 is also known as OFC6, VWS1, VWS and LPS, and its previous HGNC name was Van der Woude syndrome. NCBI Gene reports that alternate splicing of the IRF6 gene results in multiple transcript variants.

Is IRF6 linked to disease and conserved in other species?

Yes. Mutations in the IRF6 gene can cause van der Woude syndrome and popliteal pterygium syndrome, and are associated with non-syndromic orofacial cleft type 6. A mouse ortholog, Irf6, exists; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other members of the interferon regulatory factor family with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt O14896; product specifications from Assay Genie datasheets.

IRF6 Product listing